Accrued Expenses

12 Months Ended

Dec. 31, 2019

Payables and Accruals [Abstract]

Accrued Expenses

Note 4. Accrued Expenses

The following is a summary of the Company's accrued expenses:

	As of December 31,
	2019		2018
Clinical trial expenses	$	3,020,030	$	1,633,713
Other		137,356		156,976
Total	$	3,157,386	$	1,790,689